UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 8, 2021
Accession Number:
0001213900-21-020248
Submission Type:
POS AM
CIK:
0001513525
Company Name:
ADIAL PHARMACEUTICALS, INC.
File Number:
333-229615